检索结果 - James Thom

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

    Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy 由 Tim Illidge, M. Bayne, Nicholas Brown, S. Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen A. Zivanovic, Peter Johnson

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: